tiprankstipranks
Poseida Therapeutics names Syed Rizvi, M.D., as Chief Medical Officer
PremiumThe FlyPoseida Therapeutics names Syed Rizvi, M.D., as Chief Medical Officer
25d ago
Poseida Therapeutics granted FDA orphan designation for P-BCMA-ALLO1
PremiumThe Fly
Poseida Therapeutics granted FDA orphan designation for P-BCMA-ALLO1
1M ago
Poseida Therapeutics’ treatment of multiple myeloma gets FDA orphan designation
PremiumThe Fly
Poseida Therapeutics’ treatment of multiple myeloma gets FDA orphan designation
1M ago
PSTX Earnings this Week: How Will it Perform?
PremiumPre-EarningsPSTX Earnings this Week: How Will it Perform?
2M ago
Poseida Therapeutics price target raised to $10 from $8 at Piper Sandler
PremiumThe Fly
Poseida Therapeutics price target raised to $10 from $8 at Piper Sandler
4M ago
Poseida Therapeutics price target raised by $5 at H.C. Wainwright, here’s why
PremiumThe Fly
Poseida Therapeutics price target raised by $5 at H.C. Wainwright, here’s why
4M ago
Poseida Therapeutics price target lowered to $14 from $17 at Cantor Fitzgerald
PremiumThe FlyPoseida Therapeutics price target lowered to $14 from $17 at Cantor Fitzgerald
8M ago
Poseida Therapeutics reports Q2 EPS (32c), consensus (53c)
PremiumThe Fly
Poseida Therapeutics reports Q2 EPS (32c), consensus (53c)
9M ago
Poseida Therapeutics Provides Financial Results for the Second Quarter of 2023
PremiumPress Releases
Poseida Therapeutics Provides Financial Results for the Second Quarter of 2023
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100